Detalhe da pesquisa
1.
Chimeric antigen receptor T-cell therapy in acute myeloid leukemia.
Curr Opin Hematol
; 29(2): 74-83, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35013048
2.
Tonic Signaling and Its Effects on Lymphopoiesis of CAR-Armed Hematopoietic Stem and Progenitor Cells.
J Immunol
; 202(6): 1735-1746, 2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30728213
3.
Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells.
Cancer Immunol Immunother
; 68(9): 1401-1415, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31414180
4.
Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology.
J Autoimmun
; 90: 116-131, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29503042
5.
Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML.
Blood
; 137(22): 3145-3148, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33624009
6.
Loss of SPARC protects hematopoietic stem cells from chemotherapy toxicity by accelerating their return to quiescence.
Blood
; 123(26): 4054-63, 2014 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24833352
7.
Posttranscriptional regulation of c-Myc expression in adult murine HSCs during homeostasis and interferon-α-induced stress response.
Blood
; 123(25): 3909-13, 2014 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24795346
8.
Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting system.
Prostate
; 74(13): 1335-46, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25053443
9.
Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells.
Prostate
; 74(13): 1347-58, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25053504
10.
Targeting senescent cells with NKG2D-CAR T cells.
Cell Death Discov
; 10(1): 217, 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704364
11.
Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5.
Nat Cell Biol
; 8(5): 435-45, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16622421
12.
Evaluation of switch-mediated costimulation in trans on universal CAR-T cells (UniCAR) targeting CD123-positive AML.
Oncoimmunology
; 10(1): 1945804, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34290907
13.
Rapidly Switchable Universal CAR-T Cells for Treatment of CD123-Positive Leukemia.
Mol Ther Oncolytics
; 17: 408-420, 2020 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32462078
14.
C-Myc and its target FoxM1 are critical downstream effectors of constitutive androstane receptor (CAR) mediated direct liver hyperplasia.
Hepatology
; 48(4): 1302-11, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18798339
15.
Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells.
Oncotarget
; 9(7): 7487-7500, 2018 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29484126
16.
Exploratory investigation of PSCA-protein expression in primary breast cancer patients reveals a link to HER2/neu overexpression.
Oncotarget
; 8(33): 54592-54603, 2017 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28903367
17.
Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy.
Sci Rep
; 7: 42855, 2017 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28205621
18.
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells.
Oncotarget
; 8(65): 108584-108603, 2017 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29312553
19.
Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor model.
Oncoimmunology
; 6(10): e1342909, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29123951
20.
A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform.
Oncoimmunology
; 6(4): e1287246, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28507794